Background The exact mechanism by which autoantibodies against desmogleins induce acan-
Introduction
Pemphigus is a group of rare mucocutaneous autoimmune bullous diseases that are characterized by intra-epidermal IgG deposition and loss of cohesion between keratinocytes, known as acantholysis. Although the pathogenic relevance of anti-desmosomal IgG has been clearly demonstrated, the exact mechanism by which IgG induces loss of adhesion remains unsolved.
Cell signalling has received a lot of attention in the past years, including the death signalling (apoptotic) pathways. Apoptosis can be activated via an extrinsic or intrinsic pathway. In the extrinsic pathway, Fas L binds to the Fas receptor, which leads to the activation of caspase 8. In the intrinsic pathway, subsequently p53, bax, cytochrome c, and caspase 9 are activated. Both caspases 8 and 9 activate the common pathway caspase 3. Caspase 3 induces DNA fragmentation, which can be detected with poly (ADP-ribose) polymerase (PARP), fractin, and TUNEL.
1,2
Apoptosis has been suggested as an upstream event in acantholysis, but alternatively, also as a downstream event after loss of cell-cell adhesion.
3-5 4 Furthermore, it has been hypothesized that IgG might induce apoptotic enzymes but that these do not lead to cell death but instead to acantholysis, a mechanism referred to as apoptolysis.
A thorough examination of the literature on apoptosis in pemphigus revealed that the possible involvement of apoptosis in acantholysis was mainly studied in cultured cell and/or mouse models, but rarely in patient skin. 3 Despite this, the caspase pathway has already been suggested as a therapeutic target in pemphigus. 7 This, together with, as mentioned before, conflicting results from various studies, propelled us to reinvestigate this topic. We therefore searched for evidence of apoptosis in pemphigus patient skin and in an in vitro skin model, wherein we induced acantholysis by patient IgG. We checked for activation of both the intrinsic and the extrinsic pathway by immunofluorescence and, furthermore, used electron microscopy to look for hallmarks of apoptosis.
Materials and methods

Pemphigus patient skin for immunofluorescence
For immunofluorescence, we included 11 biopsies from 9 mucocutaneous pemphigus vulgaris (PV) patients (5 from healthy skin, 3 from perilesional skin, and 3 from lesional skin), and 11
biopsies from 7 pemphigus foliaceus (PF) patients (4 from healthy skin, 2 from perilesional skin, and 5 from lesional skin). Pemphigus biopsies were selected from patients with increased 
Pemphigus in vitro model for immunofluorescence
We used eight biopsies from a previously described pemphigus in vitro model experiment. 8 In these experiments, healthy breast reduction skin biopsies had been incubated with purified pemphigus IgG (for 4, 16, and 24 hours with PV IgG and for 24, 48, and 72 hours with PF IgG). The PV IgG dose was 12.2 mg/ml, the PF IgG dose was 10.8 mg/ml. After harvesting, the biopsies were frozen in liquid nitrogen and stored at -80°C. Again, the aforementioned controls (pemphigus patient skin for immunofluorescence) were evaluated in the same experiment as the in vitro model samples. Additionally, control incubations included three healthy IgG and two omission of IgG.
Staining procedure
The following antibodies were used to detect apoptosis: cleaved caspase-3 rabbit monoclonal in a humidified chamber for 60 minutes at 37ºC in dark (sections covered with cover slip during incubation). After that, the sections were counterstained with BB (1:10000 diluted in PBS) for 5 minutes at room temperature and coverslipped under SlowFade® Antifade reagent.
Evaluation of the samples
Per sample 5 high power fields were evaluated. If staining was present, between 45 and 259 keratinocytes were evaluated in the most representative high power fields, and the percentage of TUNEL was counted by two independent observers.
Pemphigus patient skin for electron microscopy
Finally, six skin biopsies (two lesional, one perilesional, and three non-lesional) from four mucocutaneous PV patients and nine skin biopsies (five lesional, one perilesional, and three nonlesional) from eight PF patients were investigated by electron microscopy for ultrastructural signs of apoptosis. Electron microscopy was performed as described before. 8 For electron microscopy, pemphigus patient skin biopsies were selected that met the same inclusion criteria as described 
Results
The apoptotic markers stained positive in the positive-control tissues but were absent in the negative controls ( Figure S1 ) were as follows: 7.46% at t=0 (non-incubated skin), 0% at t=4, 4.03% at t=16, and 3.17% at t=24. For the PF model, these percentages were 1.26% at t=0, 2.32% at t=24, 3.46% at t=48, and 1.62% at t=72 ( Figure S2 ).
All perilesional and lesional biopsies showed widening of intercellular spaces by electron microscopy. The lesional biopsies showed a decreased number of desmosomes. None of the biopsies, however, showed any morphological features of apoptosis, i.e., rounding up of the cell, retraction of pseudopods, pyknosis, karyorrhexis, plasma membrane blebbing, and engulfment by resident phagocytes (Figure 2 ). 
Discussion
In conclusion, we found no evidence of apoptotic cells in pemphigus acantholysis. First, apoptotic signalling of both the intrinsic and the extrinsic pathway was absent in 22 skin biopsies of pemphigus patients and in the in vitro model at any time point. Second, although some TUNEL staining was seen in two acantholytic PF biopsies and one PV biopsy, and in the pemphigus model, we also found TUNEL-positive cells in normal healthy skin, especially in the granular layers. The expression of TUNEL in the pemphigus skin and model was also seen in the stratum granulosum, above the blisters. If apoptosis would be a cause of acantholysis, then TUNEL positivity should have been present below the blister cavity. Third, ultrastructurally no morphological features of apoptosis were present. It should be noted that electron microscopy is considered to be the gold standard for the identification of apoptotic cells. 13 Our results are in line with the findings of Schmidt et al. who conclude that apoptosis is not required for pemphigus acantholysis.
cytes treated with PV IgG, they also found acantholysis in absence of positive TUNEL staining as well as caspase 3 cleavage. Lee et al. also disagreed that apoptosis is an upstream event in pemphigus acantholysis. 5 In PF IgG-treated mice and PV IgG-treated keratinocyte cultures, they found activation of cleaved PARP, cleaved caspase 3, and TUNEL, but only after acantholysis.
The belief that apoptosis is an upstream event in acantholysis is largely based on studies in model systems. 3 We question whether these model systems are suitable for answering such questions on pemphigus pathogenesis, as they differ from the in vivo situation. For instance, in cultured keratinocytes the desmosomal makeup in terms of molecular composition does not accurately reflect the in vivo situation. 14 As for mouse models, the repertoire of expressed genes involved in apoptosis in humans and mice is different. 15 Furthermore, previous data on pemphigus skin are scarce and based on a few lesional biopsies only. [16] [17] [18] In conclusion, this study does not support the hypothesis that apoptosis is involved in pemphigus acantholysis. However, although we studied morphological hallmarks of apoptosis, the involvement of certain apoptotic caspases or signalling pathways, which might be involved in dissociation of (inter)desmosomal adhesion complexes, cannot be excluded. 
